Agios Pharmaceuticals posted a quarterly loss of $1.58 per share versus Wall Street estimates for a loss of $1.65. This compares to loss of $1.81 per share a year ago.
Earnings showed surprise growth of 4.24%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $1.69 per share when it actually produced a loss of $1.63, delivering a surprise of 3.55% growth.